YM BioSciences Plans Floats On AIM, TSE To Raise Up To C$40M.

BioWorld International Correspondent

LONDON YM BioSciences Inc. plans to float simultaneously on the Alternative Investment Market in London and the Toronto Stock Exchange, to raise up to C$40 million gross (US$25.4 million).

David Allan, chairman and CEO, told BioWorld International, oWe expect a 50-50 split, raising C$20 million in Europe and C$20 million in Canada.

oWe are coming to Europe at the same time as floating in Toronto because 35 percent of our shareholders are in Europe, the majority of patients [in YM clinical trials] are in the UK and 25 percent of the clinical and scientific board and 33 percent of the board of directors are based [in …